Sainte-Anne hospital in Paris anticipated the application of the law of July 5th, 2011 by initiating a multi-disciplinary task force. It is important to highlight the major involvement of the directorate for legal affairs and users. This task force is now presenting an initial report on the impact on care and organisations.
Download full-text PDF |
Source |
---|
J Clin Nurs
January 2025
Department of Psychosomatic Medicine and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Background: Health care workers (HCW) with post-COVID condition (PCC) are frequently reported to suffer from mental health impairment. Given HCW above-average risk for mental health, research is necessary and risk factors need to be assessed.
Aim: To compare mental health and health of German HCW with and without PCC and to identify associated psychological and social factors.
Neuroscience
January 2025
Department of Orofacial Pain and Jaw Function, Malmö University, Malmö, Sweden; Scandinavian Center for Orofacial Neurosciences (SCON), Aarhus, Denmark; Scandinavian Center for Orofacial Neurosciences (SCON), Malmö, Sweden.
Occlusal tactile acuity (OTA) and bite force are essential components of the sensorimotor control of oral behaviors. While these variables have been studied independently, it has not yet been revealed whether compressive force impacts the occlusal perception mediated by the mechanoreceptive afferents in the periodontal ligament. The present study examined the effect of repetition and maximum bite force on OTA by testing nine aluminum foils of different thicknesses together with a sham test with no foil, three times each, in randomized order in 36 healthy individuals.
View Article and Find Full Text PDFMaturitas
November 2024
Hormone Hamburg, Hamburg, Germany. Electronic address:
Objective: To report patient-reported quality-of-life (QOL) outcomes in the DAYLIGHT study.
Study Design: DAYLIGHT was a phase 3b, randomized, double-blind, 24-week, placebo-controlled study. Participants were women aged ≥40 to ≤65 years with moderate to severe vasomotor symptoms (VMS) considered unsuitable for hormone therapy (HT) (contraindications, caution, stoppers, or averse) randomized 1:1 to placebo or fezolinetant 45 mg once daily.
J Neurol Sci
January 2025
Multiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, Italy; Department of Medical Sciences and Public Health, University of Cagliari, Italy.
Background: Migraine affects up to 40% of people with multiple sclerosis (PwMS). This study aimed to evaluate the effectiveness and safety of the combination of antibodies (mAbs) against CGRP (anti-CGRP mAbs) with disease-modifying treatments (DMTs) for MS (mAb and non-mAbs) and their impact on MS disease course.
Methods: This retrospective, multicentric study included PwMS from 14 MS Centers, treated with an anti-CGRP mAb and a stable treatment with DMTs.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!